You are viewing AANS Neurosurgeon Volume 26, Number 2, 2017. View our current issue, Volume 27, Number 1, 2018

AANS Neurosurgeon | Volume 26, Number 2, 2017

Advertisement

Neuroscientists Find Promise in Intervention to Normalize Biological Functions in Fragile X Mice

A team of neuroscientists have developed an intervention that normalizes multiple biological functions in mice afflicted with Fragile X Syndrome (FXS). Its breakthrough centers on protein synthesis, or the building of proteins, and actin dynamics, which help regulate cellular processes—two functions that are inhibited in individuals with FXS.

“Our findings are consistent with the idea that an imbalance of protein synthesis and actin dynamics contribute to physiological problems in FXS mice,” explains New York University Professor Eric Klann, director NYU’s Center for Neural Science and the study’s senior author. “Moreover, they offer a potential approach to treating individuals with Fragile X syndrome: targeting a specific protein, eIF4E, that regulates protein synthesis.”

Click here to read more.

Calendar/Courses

Second International Brain Mapping Course
April 26-27, 2018; New Orleans

Surgical Approaches to Skull Base
April 26-28, 2018; St. Louis, MO

2018 AANS Annual Scientific Meeting
April 28-May 2, 2018; New Orleans

Comments are closed.